Stock PHAS.Q PHASEBIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar PhaseBio Pharmaceuticals, Inc.

Equities

PHAS.Q

US7172241090

End-of-day quote OTC Markets
Other stock markets
 06:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for PhaseBio Pharmaceuticals, Inc. 0.00% 0.00%
Apr. 19 First Amended Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc. CI
Feb. 07 Fifth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc. CI

Chart calendar PhaseBio Pharmaceuticals, Inc.

f15da833ead8e2295d8e8ac82e5e.W96pm_sQY-EgaVOmnCC0lWtvIrSwCugYvDMLUtZHL88.KubcqsNoMswVISLf1W_-2DQiQPj0WKdrygB9GowxGbo6kdr4rFkRqGoPaw~d49f5615dadea4f4fcec877f7e2c8ed3

Upcoming events on PhaseBio Pharmaceuticals, Inc.

No events available

Past events on PhaseBio Pharmaceuticals, Inc.

2022-08-12 08:30 am Interim 2022 Earnings Release
2022-05-19 11:00 am Annual General Meeting
2022-05-16 08:30 am Business Update Call
2022-05-16 06:00 am Q1 2022 Earnings Release
2022-04-14 01:30 pm Needham Virtual Healthcare Conference
2022-04-02 12:15 pm American College of Cardiology Scientific Conference - 403-10
2022-03-24 04:00 pm FY 2021 Earnings Release
2022-03-08 12:50 pm Cowen & Co. Health Care Conference - Panel
2021-11-15 12:30 pm REVERSE-IT Phase 3 Trial Results Call
2021-11-10 04:00 pm Q3 2021 Earnings Release
2021-09-13 07:00 am H.C. Wainwright Global Investment Conference
2021-08-12 08:30 am Interim 2021 Earnings Release
2021-07-15 01:00 pm William Blair Biotech Focus Conference
2021-06-17 08:30 am Business Update Call
2021-06-02 Annual General Meeting
2021-05-13 04:00 pm Q1 2021 Earnings Release
2021-04-15 11:00 am Needham Healthcare Conference
2021-03-15 12:00 pm Analyst Day
2021-03-15 12:00 pm Investor and Analyst Day
2021-03-15 08:00 am FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2017 2018 2019 2020 2021
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,67
0,41
63.99%		2,36
1,80
31.47%		0,32
0,30
8.11%		10,8
10,5
3.01%
EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		0,00


-19,6
-21,1
6.78%		-39,7
-40,3
1.49%		-84,9
-79,6
-6.64%		-107
-106
-1.29%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-23,8
-24,2
1.46%		-39,2
-40,8
3.82%		-98,6
-87,1
-13.23%		-129
-111
-17.16%
Net income
Million USD		Released
Forecast
Spread 		-10,2


-23,8
-28,9
17.53%		-39,2
-39,6
0.77%		-98,6
-88,0
-11.95%		-131
-118
-10.86%
EPS
USD		Released
Forecast
Spread 		-13,8


-2,24
-2,39
6.08%		-1,43
-1,43
0.28%		-3,39
-3,02
-12.1%		-2,98
-2,68
-11.28%
Announcement Date21/09/1826/03/1930/03/2015/03/2124/03/22

Quarterly results

Fiscal PeriodDecember 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,13
- 		0,00
0,14
- 		0,00
0,05
- 		0,00
0,02
- 		10,3
5,02
105.94%		0,34
1,07
-68.58%		0,16
1,97
-91.96%		0,12
2,33
-94.99%		0,21
0,50
-58.4%
EBITDA
Million USD		Released
Forecast
Spread




















-18,2
-26,9
32.25%		-25,3
-20,6
-22.7%
EBIT
Million USD		Released
Forecast
Spread 		-24,1
-14,7
-64.28%		-20,5
-21,8
5.96%		-26,0
-20,7
-25.7%		-25,6
-23,2
-10.55%		-21,1
-19,3
-9.31%		-28,6
-27,8
-2.8%		-32,1
-28,6
-12.24%		-18,2
-29,8
38.9%		-25,3
-19,1
-32.33%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-28,1
-14,9
-89%		-25,1
-21,0
-19.46%		-30,4
-18,9
-60.54%		-27,4
-23,5
-16.46%		-27,1
-24,6
-9.86%		-31,9
-30,5
-4.53%		-43,1
-30,2
-42.51%		-11,1
-32,1
65.34%		-16,7
-20,6
19.21%
Net income
Million USD		Released
Forecast
Spread 		-28,1
-14,7
-91.04%		-25,1
-22,0
-14.51%		-30,4
-19,9
-52.7%		-27,4
-23,5
-16.65%		-28,7
-19,6
-46.59%		-31,9
-29,1
-9.64%		-43,1
-30,2
-42.77%		-11,1
-32,1
65.34%		-16,7
-20,6
19.21%
EPS
USD		Released
Forecast
Spread 		-0,98
-0,51
-92.16%		-0,86
-0,71
-21.47%		-1,03
-0,67
-53.73%		-0,87
-0,73
-18.53%		-0,60
-0,46
-30.43%		-0,66
-0,61
-8.91%		-0,85
-0,58
-47.19%		-0,23
-0,66
65.36%		-0,34
-0,31
-8.8%
Announcement Date11/08/2012/11/2015/03/2113/05/2112/08/2110/11/2124/03/2216/05/2212/08/22

Upcoming sector events for PhaseBio Pharmaceuticals, Inc.

2024-04-28 HITGEN INC.: Q1 2024 Earnings Release (Projected)
2024-04-28 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-30 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
2024-04-30 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for PhaseBio Pharmaceuticals, Inc.

2024-04-25 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
2024-04-25 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-25 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
2024-04-25 REMEGEN CO., LTD.: Q1 2024 Earnings Release
2024-04-25 04:05 pm PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-25 06:30 am SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-04-24 JIANGSU YAHONG MEDITECH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-24 BIO-THERA SOLUTIONS, LTD.: Q1 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHAS.Q Stock
  4. Calendar PhaseBio Pharmaceuticals, Inc.